Unbuzzd Wellness to Host Investor Webinar on Alcohol Metabolism Beverage Investment Opportunity

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) announced that its licensee Unbuzzd Wellness will host an Investor Webinar on September 16, 2025, at 1:30 p.m. PT / 4:30 p.m. ET. The event will feature CEO John Duffy, Advisor Jason Sawyer, Medical Director Dr. Eric Hoskins, and Board Co-Chair Gerry David, who will outline the current Reg D 506(c) investment opportunity, review clinical data, and highlight strategies to accelerate direct-to-consumer, distributor, and retail sales of unbuzzd(TM).

The beverage is scientifically proven to accelerate alcohol metabolism, restore mental clarity, and reduce hangover symptoms. This development represents a significant opportunity in the growing wellness and functional beverage market, particularly as consumers increasingly seek science-backed solutions for alcohol-related concerns. The timing of this investment opportunity coincides with rising consumer demand for products that address alcohol consumption effects while maintaining social enjoyment.

Quantum BioPharma retains ownership of 20.11% of Unbuzzd Wellness Inc. as of March 31, 2025, and the agreement includes royalty payments of 7% of sales from unbuzzd(TM) until payments to Quantum BioPharma total $250 million. Once $250 million is reached, the royalty drops to 3% in perpetuity. This financial structure provides long-term revenue potential for both companies while ensuring ongoing innovation in the alcohol metabolism space.

The latest news and updates relating to QNTM are available in the company's newsroom at https://ibn.fm/QNTM. Quantum BioPharma maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property. The company's diversified approach to biotechnology investments positions it well in the evolving healthcare and wellness markets.

For more information about specialized communications in the biotechnology sector, visit https://www.BioMedWire.com. The full terms of use and disclaimers applicable to all content are available at https://www.BioMedWire.com/Disclaimer. This investor webinar represents a crucial opportunity for stakeholders to understand the scientific validation and market potential of unbuzzd(TM) while learning about the investment structure that supports its commercial expansion.